eNeonatal Review

ETI (CFTR Triple Therapy): Clinical Opportunities

The advent of triple CFTR modulator therapy – ETI (elexacaftor/tezacaftor/ivacaftor) — poses a...

• 0
• 0
• 1 año

Weight Gain in PLWH: A Clinical Concern

Most people living with HIV gain weight when initiating ART. For some, the weight gain signifies...

• 0
• 0
• 1 año

Clinical Considerations for In-Development MS Treatments

Where’s the newer MS research leading? How has our understanding of noninflammatory progressive...

• 0
• 0
• 1 año

8/10/2022 - COVID-19 Testing Interview Part 2

Dr. Paul Auwaerter interviews Dr. Michael Mina about COVID-19 testing. Topics: *Why are we seeing...

• 0
• 0
• 1 año

7/28/2022 - COVID-19 Immunity Interview Part 1

Dr. Paul Auwaerter interviews Dr. Michael Mina about COVID-19 immunity. Topics: *Is COVID-19 here...

• 0
• 0
• 1 año

Pulmonary Exacerbations and IV Antibiotics

Managing pulmonary exacerbations in people with cystic fibrosis: is there high-grade evidence to...

• 0
• 0
• 1 año

COVID-19: Then and Now

What was it like for a frontline critical care pulmonologist at the very beginning of the...

• 0
• 0
• 1 año

COVID-19: The Morbidity/Mortality Risk

Are PLWH at higher risk for increased mortality from COVID-19 infection? How important is it for...

• 0
• 0
• 1 año

Nonpharmacologic Symptom Management

In this Issue: Fatigue. Urinary dysfunction. Constipation. Spasticity and gait problems....

• 0
• 0
• 1 año

Is that MS Diagnosis Accurate?

Is it true that a significant number of patients being treated for MS may not actually have the...

• 0
• 0
• 1 año

7/6/2022 - COVID-19 Vaccine Boosters

Dr. Paul Auwaerter discusses COVID-19 vaccine boosters. Topics: *Should your patients get the...

• 0
• 0
• 1 año

Race, Ethnicity, and Cystic Fibrosis

Race and ethnicity. How do they affect a patient’s ability to receive a timely and accurate...

• 0
• 0
• 1 año

6/1/2022 - State of COVID-19

Dr. Paul Auwaerter discusses the current state of COVID-19 including treatment updates. Topics:...

• 0
• 0
• 1 año

5/11/2022 - COVID-19 Omicron Impact on Vaccines

Dr. Paul Auwaerter discusses the effect of the Omicron variant, including its subvariants, on...

• 0
• 0
• 1 año

4/26/2022 - COVID-19 Prevention Update

Paul G. Auwaerter, MD, MBA, FIDSA and Michael Angarone, DO, FIDSA discuss the latest guidelines...

• 0
• 0
• 1 año

4/6/2022 - New COVID-19 Treatment Guidelines

Paul G. Auwaerter, MD, MBA, FIDSA and David Klimpl, MD discuss current treatments for patients...

• 0
• 0
• +1 año

Clinical Uses of LA Injectable ART

Long-acting injectable antiretroviral therapy is expected to improve adherence, reduce patient...

• 0
• 0
• +1 año

4/13/2022 - COVID-19 Vaccine Boosters & BA.2

Dr. Paul Auwaerter discusses new vaccine boosters, global impact of the pandemic, and the BA.2...

• 0
• 0
• +1 año

3/30/2022 - COVID-19 BA.2 Subvariant & Boosters

Dr. Paul Auwaerter discusses the BA.2 Subvariant and the recent authorization from the FDA for...

• 0
• 0
• +1 año

3/24/2022 - COVID-19 Lessons Learned

Dr. Paul Auwaerter discusses what we learned from the COVID-19 pandemic. Topics: *Reviewing the...

• 0
• 0
• +1 año